April 27, 2010 – From an announcement by the EMEA we learn that bufexamac-containing medicines were to be taken off EU markets because of high risk of contact allergies. The European Medicines Agency’s Committee for Medicinal Products for Human Use …

European Medicines Agency (EMEA) recommends revocation of marketing authorisation for bufexamac containing medicines. Read more »